Breast Cancer Update cover art

Breast Cancer Update

Breast Cancer Update

By: Dr. Neil Love
Listen for free

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.Copyright 2025 Research To Practice. All Rights Reserved Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

    Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
    Apr 30 2026

    Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the management of breast cancer.

    CME information and select publications here.

    Show More Show Less
    57 mins
  • HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

    HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
    Apr 16 2026

    Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer.

    CME information and select publications here.

    Show More Show Less
    1 hr
  • ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

    ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
    Apr 14 2026

    Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop from Yale Cancer Center in New Haven, Connecticut, review clinical research data and best practices guiding the selection of first-line and maintenance therapy for patients with ER-positive, HER2-positive metastatic breast cancer.

    CME information and select publications here.

    Show More Show Less
    58 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet